These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32995359)

  • 1. Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct.
    Chen YH; Pallant C; Sampson CJ; Boiti A; Johnson S; Brazauskas P; Hardwicke P; Marongiu M; Marinova VM; Carmo M; Sweeney NP; Richard A; Shillings A; Archibald P; Puschmann E; Mouzon B; Grose D; Mendez-Tavio M; Chen MX; Warr SRC; Senussi T; Carter PS; Baker S; Jung C; Brugman MH; Howe SJ; Vink CA
    Mol Ther Methods Clin Dev; 2020 Dec; 19():47-57. PubMed ID: 32995359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of stable suspension producer cell lines for serum-free lentivirus production.
    Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
    Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
    Kumar M; Bradow BP; Zimmerberg J
    Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
    Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
    Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
    Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
    J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
    Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
    Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
    Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
    Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
    Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
    J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
    Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
    Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor.
    Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
    Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101209. PubMed ID: 38435128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
    Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
    Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient large volume lentiviral vector production using flow electroporation.
    Witting SR; Li LH; Jasti A; Allen C; Cornetta K; Brady J; Shivakumar R; Peshwa MV
    Hum Gene Ther; 2012 Feb; 23(2):243-9. PubMed ID: 21933028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection.
    Mier NC; Roper DK
    PLoS One; 2024; 19(6):e0297817. PubMed ID: 38833479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
    Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
    Bell AJ; Fegen D; Ward M; Bank A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process.
    Tridgett M; Mulet M; Johny SP; Ababi M; Raghunath M; Fustinoni C; Galabova B; Fernández-Díaz C; Mikalajūnaitė I; Tomás HA; Kucej M; Dunajová L; Zgrundo Z; Page E; McCall L; Parker-Manuel R; Payne T; Peckett M; Kent J; Holland L; Asatryan R; Montgomery L; Chow TL; Beveridge R; Salkauskaite I; Alam MT; Hollard D; Dowding S; Gabriel HB; Branciaroli C; Cawood R; Valenti W; Chang D; Patrício MI; Liu Q
    Mol Ther Methods Clin Dev; 2024 Sep; 32(3):101315. PubMed ID: 39282073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
    Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE
    Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
    Tran MY; Kamen AA
    Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
    Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
    Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.